EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.04 Cr | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹9.04 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹-60 Cr |
| Mar2022 | ₹-73 Cr |
| Mar2021 | ₹-108 Cr |
How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.04 Cr | -77.74 | |
| Mar2024 | ₹41 Cr | Positive | |
| Mar2023 | ₹-60 Cr | Negative | |
| Mar2022 | ₹-73 Cr | Negative | |
| Mar2021 | ₹-108 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹38,119.3 Cr | 1.6% | 12.1% | 41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 1.6% |
12.1% |
41.2% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses